Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2

Mutations of hepatocyte growth factor activator inhibitor (HAI)-2 in humans cause sodium loss in the gastrointestinal (GI) tract in patients with syndromic congenital sodium diarrhea (SCSD). Aberrant regulation of HAI-2 target protease(s) was proposed as the cause of the disease. Here functional linkage of HAI-2 with two membrane-associated serine proteases, matriptase and prostasin was analyzed in Caco-2 cells and the human GI tract. Immunodepletion-immunoblot analysis showed that significant proportion of HAI-2 is in complex with activated prostasin but not matriptase. Unexpectedly, prostasin is expressed predominantly in activated forms and was also detected in complex with HAI-1, a Kunitz inhibitor highly related to HAI-2. Immunohistochemistry showed a similar tissue distribution of prostasin and HAI-2 immunoreactivity with the most intense labeling near the brush borders of villus epithelial cells. In contrast, matriptase was detected primarily at the lateral plasma membrane, where HAI-1 was also detected. The tissue distribution profiles of immunoreactivity against these proteins, when paired with the species detected suggests that prostasin is under tight control by both HAI-1 and HAI-2 and matriptase by HAI-1 in human enterocytes. Furthermore, HAI-1 is a general inhibitor of prostasin in a variety of epithelial cells. In contrast, HAI-2 was not found to be a significant inhibitor for prostasin in mammary epithelial cells or keratinocytes. The high levels of constitutive prostasin zymogen activation and the selective prostasin inhibition by HAI-2 in enterocytes suggest that dysregulated prostasin proteolysis may be particularly important in the GI tract when HAI-2 function is lost and/or dysregulated.

[1]  T. Bugge,et al.  Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin , 2016, Development.

[2]  Michael D. Johnson,et al.  Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation , 2016, PloS one.

[3]  T. Bugge,et al.  Delineation of proteolytic and non-proteolytic functions of membrane-anchored serine protease Prss 8 / prostasin 1 , 2016 .

[4]  T. Bugge,et al.  Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin* , 2015, The Journal of Biological Chemistry.

[5]  Michael D. Johnson,et al.  N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin , 2015, PloS one.

[6]  Michael D. Johnson,et al.  Differential Subcellular Localization Renders HAI-2 a Matriptase Inhibitor in Breast Cancer Cells but Not in Mammary Epithelial Cells , 2015, PloS one.

[7]  V. Zoete,et al.  The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin‐1 (PN‐1) inhibition , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Hughey,et al.  Prostasin interacts with the epithelial Na+ channel and facilitates cleavage of the γ-subunit by a second protease. , 2014, American journal of physiology. Renal physiology.

[9]  T. Bugge,et al.  The Protease Inhibitor HAI-2, but Not HAI-1, Regulates Matriptase Activation and Shedding through Prostasin* , 2014, The Journal of Biological Chemistry.

[10]  L. Schild,et al.  Functional Analysis of a Missense Mutation in the Serine Protease Inhibitor SPINT2 Associated with Congenital Sodium Diarrhea , 2014, PloS one.

[11]  Michael D. Johnson,et al.  Matriptase regulates proliferation and early, but not terminal, differentiation of human keratinocytes , 2013, The Journal of investigative dermatology.

[12]  Chen-Yong Lin,et al.  A Matriptase-Prostasin Reciprocal Zymogen Activation Complex with Unique Features , 2013, The Journal of Biological Chemistry.

[13]  Karina K. Hansen,et al.  Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation , 2012, PLoS genetics.

[14]  Michael D. Johnson,et al.  Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1. , 2012, American journal of physiology. Cell physiology.

[15]  Michael D. Johnson,et al.  Increased matriptase zymogen activation in inflammatory skin disorders. , 2011, American journal of physiology. Cell physiology.

[16]  M. Romero,et al.  Regulation of electroneutral NaCl absorption by the small intestine. , 2011, Annual review of physiology.

[17]  Michael D. Johnson,et al.  Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation* , 2010, The Journal of Biological Chemistry.

[18]  KyungMann Kim,et al.  TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. , 2010, The American journal of pathology.

[19]  L. Bird,et al.  Case of syndromic tufting enteropathy harbors SPINT2 mutation seen in congenital sodium diarrhea. , 2010, Clinical dysmorphology.

[20]  J. Kao,et al.  Matriptase Activation, an Early Cellular Response to Acidosis* , 2009, The Journal of Biological Chemistry.

[21]  J. P. Hobson,et al.  Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice , 2009, Development.

[22]  T. Bugge,et al.  Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality. , 2009, The American journal of pathology.

[23]  C. Wijmenga,et al.  Mutations in SPINT2 cause a syndromic form of congenital sodium diarrhea. , 2009, American journal of human genetics.

[24]  J. P. Hobson,et al.  Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity* , 2008, Journal of Biological Chemistry.

[25]  A. Amsterdam,et al.  Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis , 2007, Development.

[26]  C. Craik,et al.  Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway , 2007, Proceedings of the National Academy of Sciences.

[27]  A. Molinolo,et al.  Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development , 2007, Oncogene.

[28]  Chen-Yong Lin,et al.  Evidence for a Matriptase-Prostasin Proteolytic Cascade Regulating Terminal Epidermal Differentiation* , 2006, Journal of Biological Chemistry.

[29]  B. Rossier,et al.  Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1. , 2006, Journal of the American Society of Nephrology : JASN.

[30]  R. Dickson,et al.  HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. , 2005, American journal of physiology. Cell physiology.

[31]  R. Dickson,et al.  Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. , 2005, American journal of physiology. Cell physiology.

[32]  Karen Billeci,et al.  Hepsin activates pro‐hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor‐1B (HAI‐1B) and HAI‐2 , 2005, FEBS letters.

[33]  Aaron Shipway,et al.  Biochemical characterization of prostasin, a channel activating protease. , 2004, Biochemical and biophysical research communications.

[34]  K. Chai,et al.  Regulation of prostasin expression and function in the prostate , 2004, The Prostate.

[35]  Baljit Singh,et al.  Characterization of Matriptase Expression in Normal Human Tissues , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  R. Dickson,et al.  The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor* , 2003, Journal of Biological Chemistry.

[37]  L. Chao,et al.  Prostasin Is a Glycosylphosphatidylinositol-anchored Active Serine Protease* , 2001, The Journal of Biological Chemistry.

[38]  R. Dickson,et al.  Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. , 2001, European journal of biochemistry.

[39]  K. Nabeshima,et al.  Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas. , 2000, Cancer letters.

[40]  M. Johnson,et al.  Purification and Characterization of a Complex Containing Matriptase and a Kunitz-type Serine Protease Inhibitor from Human Milk* , 1999, The Journal of Biological Chemistry.

[41]  K. Nabeshima,et al.  Distribution of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) in Human Tissues: Cellular Surface Localization of HAI-1 in Simple Columnar Epithelium and Its Modulated Expression in Injured and Regenerative Tissues , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  G. Giebisch,et al.  Renal and intestinal absorptive defects in mice lacking the NHE3 Na +/H+ exchanger , 1998, Nature Genetics.

[43]  K. Matsumoto,et al.  Purification and Cloning of Hepatocyte Growth Factor Activator Inhibitor Type 2, a Kunitz-type Serine Protease Inhibitor* , 1997, The Journal of Biological Chemistry.

[44]  B. Rossier,et al.  An epithelial serine protease activates the amiloride-sensitive sodium channel , 1997, Nature.

[45]  J. Greve,et al.  Identification and Cloning of Human Placental Bikunin, a Novel Serine Protease Inhibitor Containing Two Kunitz Domains* , 1997, The Journal of Biological Chemistry.

[46]  R. Dickson,et al.  Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells , 1997, The Journal of Biological Chemistry.

[47]  D. Lawrence,et al.  Serpin-Protease Complexes Are Trapped as Stable Acyl-Enzyme Intermediates (*) , 1995, The Journal of Biological Chemistry.

[48]  Lee Chao,et al.  Molecular Cloning, Tissue-specific Expression, and Cellular Localization of Human Prostasin mRNA (*) , 1995, The Journal of Biological Chemistry.

[49]  P. Milla,et al.  DEFECTIVE JEJUNAL BRUSH-BORDER Na+/H+ EXCHANGE: A CAUSE OF CONGENITAL SECRETORY DIARRHOEA , 1985, The Lancet.

[50]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Perheentupa,et al.  Congenital Na+ diarrhea: a new type of secretory diarrhea. , 1985, The Journal of pediatrics.

[52]  M. Lazdunski,et al.  Pre‐existence of the active site in zymogens, the interaction of trypsinogen with the basic pancreatic trypsin inhibitor (Kunitz) , 1976, FEBS letters.

[53]  M. Lazdunski,et al.  Trypsin-pancreatic trypsin inhibitor association. Dynamics of the interaction and role of disulfide bridges. , 1972, Biochemistry.

[54]  V. Zoete,et al.  Title : The CAP 1 / Prss 8 catalytic triad is not involved in PAR 2 activation and protease nexin-1 ( PN-1 ) inhibition , 2022 .